Child psychiatrist Dr. Miriam Grossman testified before the House Committee on Energy and Commerce’s Subcommittee on Health that child transgender procedures present a significant risk of harm.
The FDA has "repeatedly stated that effectiveness against transmission remains unproven," the trio write, noting that the agency’s website maintains: "the scientific community does not yet know if Comirnaty will reduce such transmission."